1 Min Read
Feb 9 (Reuters) - Replicel Life Sciences Inc
* Announced granting of two patents in Europe related to its multi-needle dermal injection technologies Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.